Combination HRT raises women's risk of lung cancer

02/25/2010 | Reuters

Hormone replacement therapy containing estrogen and progestin increases the risk of lung cancer in women, according to study data. Women who used the combination HRT for 10 years or more were almost 50% more likely to be diagnosed with lung cancer compared with nonusers, even after taking into consideration age and smoking history.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC